PT Merck Tbk Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com
| MERK Stock | IDR 3,360 50.00 1.47% |
About 62% of Merck Tbk's investor base is looking to short. The analysis of current outlook of investing in Merck Tbk suggests that many traders are alarmed regarding Merck Tbk's prospects. Merck Tbk's investing sentiment shows overall attitude of investors towards Merck Tbk.
Merck |
PT Merck Tbk Reports Earnings Results for the Half Year Ended June 30, 2024 Marketscreener.com
Read at news.google.com
 |
Merck Tbk Fundamental Analysis
We analyze Merck Tbk's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck Tbk using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck Tbk based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Merck Tbk is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Merck Tbk Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Merck Tbk stock to make a market-neutral strategy. Peer analysis of Merck Tbk could also be used in its relative valuation, which is a method of valuing Merck Tbk by comparing valuation metrics with similar companies.
Peers
Merck Tbk Related Equities
| MLBI | Multi Bintang | 0.82 |
| ||
| PYFA | Pyridam Farma | 1.55 |
| ||
| TSPC | Tempo Scan | 3.10 |
| ||
| MRAT | Mustika Ratu | 3.25 |
| ||
| DVLA | Darya Varia | 3.73 |
|
Other Information on Investing in Merck Stock
Merck Tbk financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck Tbk security.